Pre-Conference Workshops
Tuesday, October 19, 2021


Turning Cold Tumors Hot Through Novel Combination Approaches
10.00 am - 12.00 pm

Beyond T Cells: Understanding the Ecosystem of Hot Tumors

  • Review the cellular components of hot versus cold tumor microenvironments, and the underlying tumor-intrinsic genomic features
  • Describe the role of B cells and plasma cells in anti-tumor immunity
  • Discuss how orthogonal immune mechanisms can synergize to control tumors

Combination with TILs to Improve Outcomes

  • Outline current progress with TILs plus targeted therapy
  • Assess results of TILs plus checkpoint inhibitors
  • Question how to position combos with TILs in the current treatment arena

Workshop Leaders

Marco Donia

Marco Donia
Research Group Leader
Herlev Hospital

Brad Nelson Feb 2021

Brad Nelson
Director & Distinguished Scientist
BC Cancer Deeley Research Centre


QC & Potency Assay Development to Bridge Clinical Data and Remove Variability
1.00 pm - 3.00 pm

Early Phase Cell Therapy Product Development: Potency Assays

  • Acquire knowledge of the regulatory expectations for potency assay rigor in early or late phase clinical trials
  • Observe relevant examples of potency assay application for a representative cell therapy product
  • Determine when and what test methods to apply during cell therapy product characterization and validation

Workshop Leader

Cheryl Cox

Cheryl Cox
Cell Therapy Core Operations Director
Moffitt Cancer Center


Matthew Beatty
Research Scientist
Moffitt Cancer Center